FDA’s Digital Health Advisory Committee Considers Generative AI Therapy Chatbots for Depression

The U.S. Food and Drug Administration’s (FDA) Digital Health Advisory Committee (DHAC) held a public meeting on “Generative Artificial Intelligence-Enabled Digital Mental Health Medical Devices,” with a particular focus on a hypothetical prescription large language model (LLM) therapy chatbot for adults with major depressive disorder (MDD)….
By: Orrick, Herrington & Sutcliffe LLP